Bectas Therapeutics
Core Members
Bectas Therapeutics is a preclinical-stage biotech company developing monoclonal antibody therapies for cancer accompanied by biomarkers to identify patients that will most benefit from each Bectas Therapeutic antibody. Our programs combine monoclonal antibodies that exhibit best-in-class pre-clinical activity with precision insights that enable first-in-class therapies to serve patients across multiple cancer indications, auto-immunity and metabolic diseases Core Membership
Bectas Therapeutics
Categories
About
Membership Type